Suchergebnisse - "Chapman, Sonya C"

PubPharm (41)

31

Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer : A Phase I Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Autio, K. | Klebanoff, C. | Schaer, D. | +27

32

A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Tolaney, S. | Sahebjam, S. | Le Rhun, E. | +13

ErratumIn: Clin Cancer Res. 2021 Mar 1;27(5):1582. - PMID 33649192

33

Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2020

von Turner, P. | Hall, S. | Chapman, S. | +4

34

Opportunities for Quantitative Translational Modeling in Oncology

enthalten in: Clinical pharmacology and therapeutics | 2020

von Yates, J. | Byrne, H. | Chapman, S. | +13

35

Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER) : a randomised, open-label, phase 2 trial

enthalten in: The Lancet. Oncology | 2020

von Tolaney, S. | Wardley, A. | Zambelli, S. | +14

CommentIn: Lancet Oncol. 2020 Jun;21(6):734-735. - PMID 32353343

36

Impact of tumour size measurement inter-operator variability on model-based drug effect evaluation

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Lombard, A. | Mistry, H. | Chapman, S. | +3

37

Impact of tumour size measurement inter-operator variability on model-based drug effect evaluation

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Lombard, A. | Mistry, H. | Chapman, S. | +3

38

Impact of tumour size measurement inter-operator variability on model-based drug effect evaluation

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Lombard, A. | Mistry, H. | Chapman, S. | +3

39

Impact of tumour size measurement inter-operator variability on model-based drug effect evaluation

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Lombard, A. | Mistry, H. | Chapman, S. | +3

40

Opportunities for Quantitative Translational Modeling in Oncology

enthalten in: Clinical Pharmacology & Therapeutics | 2020

von Yates, J. | Byrne, H. | Chapman, S. | +13